COLON POLYP DIAGNOSIS BY VOLUME MICROPROBE SPECTROSCOPY

Information

  • Research Project
  • 2422969
  • ApplicationId
    2422969
  • Core Project Number
    R43CA075773
  • Full Project Number
    1R43CA075773-01
  • Serial Number
    75773
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/8/1997 - 26 years ago
  • Project End Date
    12/31/1999 - 24 years ago
  • Program Officer Name
    WU, ROY S
  • Budget Start Date
    9/8/1997 - 26 years ago
  • Budget End Date
    12/31/1999 - 24 years ago
  • Fiscal Year
    1997
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/8/1997 - 26 years ago
Organizations

COLON POLYP DIAGNOSIS BY VOLUME MICROPROBE SPECTROSCOPY

The goal of this research program is the application of optical biopsy techniques to the identification of adenomatous polyps in the colon. Specific optical instrumentation and software will be developed for this task. Spectroscopic detection of dysplasia has been demonstrated, and is accepted. It has been shown to be sensitive and selective, especially if the tissue volume being sampled is confined to the mucosal layer. For this reason, we propose a technique similar to confocal microscopy, which we Volume MicroProbe microscopy. This optical technique is ideally suited for operation through the working channel of a typical colonoscope. Clinical trials with human subjects are included in the application. PROPOSED COMMERCIAL APPLICATION: Colorectal cancer claims approximately 60,000 individuals in the US annually. It is a highly curable disease if detected in its early stages. The proposed optical biopsy instrumentation will improve diagnostic capability and may modify current practice of removing small benign hyperplastic polyps which are indistinguishable from precancerous polyps. Therefore, the commercial potential is high, especially considering that approximately 15.5M colonoscopes and sigmoidoscopies are performed in the US each year. If even 10% of these procedures include an optical biopsy, the number of optical procedures will be over 1.6M annually.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG2
  • Study Section Name
  • Organization Name
    MEDISPECTRA, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    LEXINGTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02421
  • Organization District
    UNITED STATES